Tomás Pascual (T Pascual, Tomas Pascual)

Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 27

Top Venues

NPJ breast cancer

Nature communications

Clinical cancer research : an official journal of the American Association for Cancer Research

Future oncology (London, England)

University of North Carolina Lineberger Comprehensive Cancer Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of North Carolina Lineberger Comprehensive Cancer Center Oct 10 2019

United States

Postdoctoral Research Associate :: Charles M. Perou Laboratory

Solti Dec 01 2016

Spain

Medical Advisor

Hospital Clinic of Barcelona Nov 01 2016 - Sep 30 2019

Spain

MD :: Medical Oncology

Hospital Universitario de la Princesa Jun 01 2015 - Aug 31 2016

Spain

MD :: Medical Oncology, Breast Cancer Unit

Hospital Universitario 12 de Octubre May 21 2014 - May 31 2015

Spain

MD :: Medical Oncology Deparment, Breast Cancer Unit

Hospital Universitario 12 de Octubre May 20 2009 - May 20 2014

Spain

Medical Oncology Fellowship :: Medical Oncology Department

Publications

Fara Brasó-Maristany, Juan Manuel Ferrero-Cafiero, Claudette Falato, Adrienne G Waks, Juan Miguel Cejalvo, Mireia Margelí, Pablo Tolosa, Francisco Javier Salvador-Bofill, Josefina Cruz, Blanca González-Farré, Esther Sanfeliu, Andreu Òdena, Violeta Serra, Francisco J Pardo-Palacios, Ana María Luna Barrera, Miriam Arumi, Juan Antonio Guerra, Guillermo Villacampa, Rodrigo Sánchez-Bayona, Eva Ciruelos, Martín Espinosa-Bravo, Yann Izarzugaza, Patricia Galván, Judith Matito, Sonia Pernas, María Jesús Vidal Losada, Anu Santhanagopal, Dalila Sellami, Stephen Esker, Pang-Dian Fan, Fumitaka Suto, Ana Vivancos, Tomás Pascual, Aleix Prat, Mafalda Oliveira
Patritumab deruxtecan in HER2-negative breast cancer: part B results of the window-of-opportunity SOLTI-1805 TOT-HER3 trial and biological determinants of early response. Nature communications 15 (1) (2024)
Tomás Pascual, Aranzazu Fernandez-Martinez, Yash Agrawal, Adam D Pfefferle, Nuria Chic, Fara Brasó-Maristany, Blanca Gonzàlez-Farré, Laia Paré, Guillermo Villacampa, Cristina Saura, Cristina Hernando, Montserrat Muñoz, Patricia Galván, Xavier Gonzàlez-Farré, Mafalda Oliveira, Miguel Gil-Gil, Eva Ciruelos, Patricia Villagrasa, Joaquín Gavilá, Aleix Prat, Charles M Perou
Cell-cycle inhibition and immune microenvironment in breast cancer treated with ribociclib and letrozole or chemotherapy. NPJ breast cancer 10 (1) (2024)
Tomás Pascual, Aranzazu Fernandez-Martinez, Yash Agrawal, Adam D Pfefferle, Nuria Chic, Fara Brasó-Maristany, Blanca Gonzàlez-Farré, Laia Paré, Guillermo Villacampa, Cristina Saura, Cristina Hernando, Montserrat Muñoz, Patricia Galván, Xavier Gonzàlez-Farré, Mafalda Oliveira, Miguel Gil-Gil, Eva Ciruelos, Patricia Villagrasa, Joaquín Gavilá, Aleix Prat, Charles M Perou
Cell-cycle inhibition and immune microenvironment in breast cancer treated with ribociclib and letrozole or chemotherapy. NPJ breast cancer 10 (1) (2024)
Leonard Schmiester, Fara Brasó-Maristany, Blanca Gonzalez-Farre, Tomás Pascual, Joaquín Gavilá, Xavier Tekpli, Jürgen Geisler, Vessela N Kristensen, Arnoldo Frigessi, Aleix Prat, Alvaro Köhn-Luque
Computational Model Predicts Patient Outcomes in Luminal B Breast Cancer Treated with Endocrine Therapy and CDK4/6 Inhibition. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (17) (2024)
Adrienne G Waks, Olga Martínez-Sáez, Paolo Tarantino, Fara Braso-Maristany, Tomás Pascual, Javier Cortes, Sara M Tolaney, Aleix Prat
Dual HER2 inhibition: mechanisms of synergy, patient selection, and resistance. Nature reviews. Clinical oncology (2024)
Fara Brasó-Maristany, Juan Manuel Ferrero-Cafiero, Claudette Falato, Adrienne G Waks, Juan Miguel Cejalvo, Mireia Margelí, Pablo Tolosa, Francisco Javier Salvador-Bofill, Josefina Cruz, Blanca González-Farré, Esther Sanfeliu, Andreu Òdena, Violeta Serra, Francisco J Pardo-Palacios, Ana María Luna Barrera, Miriam Arumi, Juan Antonio Guerra, Guillermo Villacampa, Rodrigo Sánchez-Bayona, Eva Ciruelos, Martín Espinosa-Bravo, Yann Izarzugaza, Patricia Galván, Judith Matito, Sonia Pernas, María Jesús Vidal Losada, Anu Santhanagopal, Dalila Sellami, Stephen Esker, Pang-Dian Fan, Fumitaka Suto, Ana Vivancos, Tomás Pascual, Aleix Prat, Mafalda Oliveira
Patritumab deruxtecan in HER2-negative breast cancer: part B results of the window-of-opportunity SOLTI-1805 TOT-HER3 trial and biological determinants of early response. Nature communications 15 (1) (2024)
Tomás Pascual, Aranzazu Fernandez-Martinez, Yash Agrawal, Adam D Pfefferle, Nuria Chic, Fara Brasó-Maristany, Blanca Gonzàlez-Farré, Laia Paré, Guillermo Villacampa, Cristina Saura, Cristina Hernando, Montserrat Muñoz, Patricia Galván, Xavier Gonzàlez-Farré, Mafalda Oliveira, Miguel Gil-Gil, Eva Ciruelos, Patricia Villagrasa, Joaquín Gavilá, Aleix Prat, Charles M Perou
Cell-cycle inhibition and immune microenvironment in breast cancer treated with ribociclib and letrozole or chemotherapy. NPJ breast cancer 10 (1) (2024)
Fara Brasó-Maristany, Juan Manuel Ferrero-Cafiero, Claudette Falato, Adrienne G Waks, Juan Miguel Cejalvo, Mireia Margelí, Pablo Tolosa, Francisco Javier Salvador-Bofill, Josefina Cruz, Blanca González-Farré, Esther Sanfeliu, Andreu Òdena, Violeta Serra, Francisco J Pardo-Palacios, Ana María Luna Barrera, Miriam Arumi, Juan Antonio Guerra, Guillermo Villacampa, Rodrigo Sánchez-Bayona, Eva Ciruelos, Martín Espinosa-Bravo, Yann Izarzugaza, Patricia Galván, Judith Matito, Sonia Pernas, María Jesús Vidal Losada, Anu Santhanagopal, Dalila Sellami, Stephen Esker, Pang-Dian Fan, Fumitaka Suto, Ana Vivancos, Tomás Pascual, Aleix Prat, Mafalda Oliveira
Patritumab deruxtecan in HER2-negative breast cancer: part B results of the window-of-opportunity SOLTI-1805 TOT-HER3 trial and biological determinants of early response. Nature communications 15 (1) (2024)
Leonard Schmiester, Fara Brasó-Maristany, Blanca Gonzalez-Farre, Tomás Pascual, Joaquín Gavilá, Xavier Tekpli, Jürgen Geisler, Vessela N Kristensen, Arnoldo Frigessi, Aleix Prat, Alvaro Köhn-Luque
Computational model predicts patient outcomes in Luminal B breast cancer treated with endocrine therapy and CDK4/6 inhibition. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Tomás Pascual, Aranzazu Fernandez-Martinez, Yash Agrawal, Adam D Pfefferle, Nuria Chic, Fara Brasó-Maristany, Blanca Gonzàlez-Farré, Laia Paré, Guillermo Villacampa, Cristina Saura, Cristina Hernando, Montserrat Muñoz, Patricia Galván, Xavier Gonzàlez-Farré, Mafalda Oliveira, Miguel Gil-Gil, Eva Ciruelos, Patricia Villagrasa, Joaquín Gavilá, Aleix Prat, Charles M Perou
Cell-cycle inhibition and immune microenvironment in breast cancer treated with ribociclib and letrozole or chemotherapy. NPJ breast cancer 10 (1) (2024)
Aleix Prat, Fara Brasó-Maristany, Adrienne G Waks, Esther Sanfeliu, Youli Xia, Meritxell Bellet-Ezquerra, Patricia Galván, Débora Martínez, Tomás Pascual, Mercedes Marín-Aguilera, Anna Rodríguez, Nuria Chic, Barbara Adamo, Laia Paré, María Jesús Vidal Losada, Mireia Margelí, Ester Ballana, Marina Gómez-Rey, Mafalda Oliveira, Eudald Felip, Judit Matito, Rodrigo Sánchez-Bayona, Anna Suñol, Cristina Saura, Eva Ciruelos, P Tolosa Ortega, Montserrat Muñoz, Blanca González-Farré, Patricia Villagrasa, Joel S Parker, Charles M Perou, Ana Vivancos
Circulating tumor DNA reveals complex biological features with clinical relevance in metastatic breast cancer. Nature communications 14 (1) (2023)
Aleix Prat, Fara Brasó-Maristany, Adrienne G Waks, Esther Sanfeliu, Youli Xia, Meritxell Bellet-Ezquerra, Patricia Galván, Débora Martínez, Tomás Pascual, Mercedes Marín-Aguilera, Anna Rodríguez, Nuria Chic, Barbara Adamo, Laia Paré, María Jesús Vidal Losada, Mireia Margelí, Ester Ballana, Marina Gómez-Rey, Mafalda Oliveira, Eudald Felip, Judit Matito, Rodrigo Sánchez-Bayona, Anna Suñol, Cristina Saura, Eva Ciruelos, P Tolosa Ortega, Montserrat Muñoz, Blanca González-Farré, Patricia Villagrasa, Joel S Parker, Charles M Perou, Ana Vivancos
Circulating tumor DNA reveals complex biological features with clinical relevance in metastatic breast cancer. Nature communications 14 (1) (2023)
Jamunarani Veeraraghavan, Carolina Gutierrez, Carmine De Angelis, Robert Davis, Nicholas Wang, Tomás Pascual, Pier Selenica, Katherine Sanchez, Hiroaki Nitta, Monesh Kapadia, Anne C Pavlick, Patricia Galván, Brent N Rexer, Andres Forero-Torres, Rita Nanda, Anna Maria V Storniolo, Ian E Krop, Matthew P Goetz, Julie R Nangia, Antonio C Wolff, Jorge S Reis-Filho, Jorge Sergio Reis-Filho, Susan G Hilsenbeck, Aleix Prat, C Kent Osborne, Rachel Schiff, Mothaffar F Rimawi
A multiparameter molecular classifier to predict response to neoadjuvant lapatinib plus trastuzumab without chemotherapy in HER2+ breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Francesco Schettini, Nuria Chic, Fara Brasó-Maristany, Laia Paré, Tomás Pascual, Benedetta Conte, Olga Martínez-Sáez, Barbara Adamo, María Jesús Vidal Losada, Esther Barnadas, Aranzazu Fernández-Martinez, Blanca González-Farre, Esther Sanfeliu, Juan Miguel Cejalvo, Giuseppe Perrone, Giovanna Sabarese, Francesca Zalfa, Vicente Peg, Roberta Fasani, Patricia Villagrasa, Joaquín Gavilá, Carlos Henrique Barrios, Ana Lluch, Miguel Martín, Mariavittoria Locci, Sabino De Placido, Aleix Prat
Author Correction: Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer. NPJ breast cancer 9 (1) (2023)
Aleix Prat, Fara Brasó-Maristany, Adrienne G Waks, Esther Sanfeliu, Youli Xia, Meritxell Bellet-Ezquerra, Patricia Galván, Débora Martínez, Tomás Pascual, Mercedes Marín-Aguilera, Anna Rodríguez, Nuria Chic, Barbara Adamo, Laia Paré, María Jesús Vidal Losada, Mireia Margelí, Ester Ballana, Marina Gómez-Rey, Mafalda Oliveira, Eudald Felip, Judit Matito, Rodrigo Sánchez-Bayona, Anna Suñol, Cristina Saura, Eva Ciruelos, P Tolosa Ortega, Montserrat Muñoz, Blanca González-Farré, Patricia Villagrasa, Joel S Parker, Charles M Perou, Ana Vivancos
Circulating tumor DNA reveals complex biological features with clinical relevance in metastatic breast cancer. Nature communications 14 (1) (2023)
Aleix Prat, Fara Brasó-Maristany, Adrienne G Waks, Esther Sanfeliu, Youli Xia, Meritxell Bellet-Ezquerra, Patricia Galván, Débora Martínez, Tomás Pascual, Mercedes Marín-Aguilera, Anna Rodríguez, Nuria Chic, Barbara Adamo, Laia Paré, María Jesús Vidal Losada, Mireia Margelí, Ester Ballana, Marina Gómez-Rey, Mafalda Oliveira, Eudald Felip, Judit Matito, Rodrigo Sánchez-Bayona, Anna Suñol, Cristina Saura, Eva Ciruelos, P Tolosa Ortega, Montserrat Muñoz, Blanca González-Farré, Patricia Villagrasa, Joel S Parker, Charles M Perou, Ana Vivancos
Circulating tumor DNA reveals complex biological features with clinical relevance in metastatic breast cancer. Nature communications 14 (1) (2023)
Francesco Schettini, Nuria Chic, Fara Brasó-Maristany, Laia Paré, Tomás Pascual, Benedetta Conte, Olga Martínez-Sáez, Barbara Adamo, María Jesús Vidal Losada, Esther Barnadas, Aranzazu Fernández-Martinez, Blanca González-Farre, Esther Sanfeliu, Juan Miguel Cejalvo, Giuseppe Perrone, Giovanna Sabarese, Francesca Zalfa, Vicente Peg, Roberta Fasani, Patricia Villagrasa, Joaquín Gavilá, Carlos Henrique Barrios, Ana Lluch, Miguel Martín, Mariavittoria Locci, Sabino De Placido, Aleix Prat
Author Correction: Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer. NPJ breast cancer 9 (1) (2023)
Aleix Prat, Luis G Paz-Ares, Manel Juan, Enriqueta Felip Font, Elena Garralda, Blanca Gonzalez-Farre, Ana M Arance, Juan Martín-Liberal, Joaquín Gavilá, Ana López-González, Juan Miguel Cejalvo, Yann Izarzugaza, Kepa Amillano, Javier García Corbacho, Cristina Saura, Fabricio Racca, Cinta Hierro, Esther Sanfeliu, Xavier Gonzalez, Jordi Canes, Guillermo Villacampa, Fernando Salvador, Tomás Pascual, Ricard Mesía, Andres Cervantes, Josep Tabernero
SOLTI-1904 ACROPOLI TRIAL: efficacy of spartalizumab monotherapy across tumor-types expressing high levels of PD1 mRNA. Future oncology (London, England) (2022)
Tomás Pascual, Aranzazu Fernandez-Martinez, Maki Tanioka, Maria Vittoria Dieci, Sonia Pernas, Joaquin Gavila, Valentina Guarnieri, Javier Cortes, Patricia Villagrasa, Núria Chic, María Jesús Vidal Losada, Barbara Adamo, Montserrat Muñoz, Gaia Griguolo, Antonio Llombart, PierFranco Conte, Mafalda Oliveira, Benedetta Conte, Laia Paré, Patricia Galvan, Lisa Anne Carey, Charles M Perou, Aleix Prat
Independent Validation of the PAM50-Based Chemo-Endocrine Score (CES) in Hormone Receptor-Positive HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2-Based Therapy. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (11) (2021)
Gaia Griguolo, Garazi Serna, Tomás Pascual, R Fasani, X Guardia, N Chic, L Paré, S Pernas, M Muñoz, Mafalda Oliveira, María Jesús Vidal Losada, A Llombart-Cussac, J Cortés, P Galván, B Bermejo, N Martínez, R López, Serafin Morales Murillo, I Garau, Luis Manso Sanchez, J Alarcón, E Martínez, P Villagrasa, Aleix Prat, Paolo G Nuciforo
Immune microenvironment characterisation and dynamics during anti-HER2-based neoadjuvant treatment in HER2-positive breast cancer. NPJ precision oncology 5 (1) (2021)
Olga Martínez-Sáez, Tomás Pascual, Fara Brasó-Maristany, Nuria Chic, Blanca González-Farré, Esther Sanfeliu, Adela Rodríguez, Débora Martínez, Patricia Galván, Anna Belén Rodríguez, Francesco Schettini, Benedetta Conte, María Jesús Vidal Losada, Barbara Adamo, Antonio Martinez-Pozo, Montserrat Muñoz, Reinaldo Moreno, Patricia Villagrasa, Fernando Salvador, Eva M Ciruelos, Iris Faull, Justin I Odegaard, Aleix Prat
Circulating tumor DNA dynamics in advanced breast cancer treated with CDK4/6 inhibition and endocrine therapy. NPJ breast cancer 7 (1) (2021)
Francesco Schettini, Nuria Chic, Fara Brasó-Maristany, Laia Paré, Tomás Pascual, Benedetta Conte, Olga Martínez-Sáez, Barbara Adamo, María Jesús Vidal Losada, Esther Barnadas, Aranzazu Fernández-Martinez, Blanca González-Farre, Esther Sanfeliu, Juan Miguel Cejalvo, Giuseppe Perrone, Giovanna Sabarese, Francesca Zalfa, Vicente Peg, Roberta Fasani, Patricia Villagrasa, Joaquín Gavilá, Carlos Henrique Barrios, Ana Lluch, Miguel Martín, Mariavittoria Locci, Sabino De Placido, Aleix Prat
Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer. NPJ breast cancer 7 (1) (2021)
Gaia Griguolo, Fara Brasó-Maristany, Blanca González-Farré, Tomás Pascual, Núria Chic, Tamara Saurí, Ronald Kates, Oleg Gluz, Débora Martínez, Laia Paré, Vassilena Tsvetkova, David Pesantez, Maria Vidal, Barbara Adamo, Montserrat Muñoz, Patricia Galván, Laura Barberá, Miriam Cuatrecasas, Mathias Christgen, Hans Kreipe, Inés Monge-Escartín, Patricia Villagrasa, Dolors Soy, Tommaso Giarratano, Maria Vittoria Dieci, PierFranco Conte, Nadia Harbeck, Valentina Guarneri, Aleix Prat
ERBB2 mRNA Expression and Response to Ado-Trastuzumab Emtansine (T-DM1) in HER2-Positive Breast Cancer. Cancers 12 (7) (2020)
Aleix Prat, Yi-Hsuan Tsai, Tomás Pascual, Laia Paré, Barbara Adamo, María Jesús Vidal Losada, Fara Brasó-Maristany, Patricia Galván, Jan Christoph Brase, Vanessa Rodrik-Outmezguine, Stephen Johnston, Eva Ciruelos Gil, Joel S Parker
A Prognostic Model Based on PAM50 and Clinical Variables (PAM50MET) for Metastatic Hormone Receptor-positive HER2-negative Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (23) (2020)
Fara Brasó-Maristany, Gaia Griguolo, Tomás Pascual, Laia Paré, Paolo G Nuciforo, Antonio Llombart-Cussac, Begoña Bermejo, Mafalda Oliveira, Serafín Morales, Noelia Martínez, Maria Vidal, Barbara Adamo, Adrienne G Waks, Sonia Pernas, Rafael López, Montserrat Muñoz, Núria Chic, Patricia Galván, Isabel Garau, Luis Manso, Jesús Alarcón, Eduardo Martínez, Sara Gregorio, Roger R Gomis, Patricia Villagrasa, Javier Cortés, Eva Ciruelos, Aleix Prat
Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade. Nature communications 11 (1) (2020)
Eva Ciruelos Gil, Patricia Villagrasa, Tomás Pascual, Mafalda Oliveira, Sonia Pernas, Laia Paré, Santiago Escriva-de-Romani, Luis Manso Sanchez, Barbara Adamo, E Martínez de Dueñas, Javier Cortes, Silvia Vazquez, Antonia Perelló, Isabel Garau, Mireia Melé, Alvaro Montaño, Begoña Bermejo, Serafin Morales Murillo, María J Echarri, Estela Vega, Blanca Gonzalez-Farre, Patricia Galván, Jordi Canes, Paolo G Nuciforo, Xavier Gonzalez, Aleix Prat
Palbociclib and Trastuzumab in HER2-Positive Advanced Breast Cancer: Results from the Phase II SOLTI-1303 PATRICIA Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (22) (2020)
Tomás Pascual, Juan M Cejalvo, Mafalda Oliveira, Maria Vidal, Estela Vega, Sergi Ganau, Ana Julve, Esther Zamora, Ignacio Miranda, Ana Delgado, Begoña Bermejo, Luis de la Cruz-Merino, Manel Juan, Juan M Ferrero-Cafiero, Jordi Canes, Xavier Gonzalez, Patricia Villagrasa, Aleix Prat
SOLTI-1503 PROMETEO TRIAL: combination of talimogene laherparepvec with atezolizumab in early breast cancer. Future oncology (London, England) 16 (24) (2020)

Tomás Pascual.css-eqlu8i{font-size:small;padding-left:4px;} (T Pascual, Tomas Pascual)

Publication Activity (10 Years)

Top Topics

Top Venues

Tomás Pascual (T Pascual, Tomas Pascual)